Koustav sarkar

PhD from Jadavpur University/Chittaranjan National Cancer Institute, Kolkata, West Bengal, India
M,Sc. from Banaras Hindu University, Varanasi, Uttar Pradesh, India
B.Sc. from University of Calcutta, Kolkata, West Bengal, India

My research focuses on explicating the molecular underpinnings of immune dysregulation and cancer immunotherapy. The broad components of my research interests are:
1. Immune dysregulation
2. Cancer immunotherapy

Independent Research Grant(s):
1. As Principal Investigator (PI):
Title of the project: “Wiskott Aldrich Syndrome protein (WASp) mediated epigenetic regulation of T helper (Th) cell differentiation linked to malignancies through R-loop modulation”.
Funding Agency: SERB, DST, Govt. of India
Date of Start: March 03, 2017; Duration: 36 months; Sanctioned amount: Rs. 44,45,210/-
2. As Co-PI:
Title of the project: “Therapeutic potential of Nrf2 activators on endoplasmic reticulum stress-induced endothelial dysfunction in diabetes”.
Funding Agency: SERB, DST Govt. of India
Date of Start: October 09, 2017, Duration: 36 months; Sanctioned amount: Rs. 50,54,200/-

Grant(s) received for conducting international Conference:
As convener:
Title of the conference: “International Conference on Immunology (Theme: Major breakthroughs and advances in immunology for human diseases)”
i. Funding Agency: SERB, DST, Govt. of India
Duration: 3 days (September 26-28, 2018). Sanctioned amount: Rs. 2,00,000/-
ii. Funding Agency: Department of Biotechnology (DBT), Govt. of India
Duration: 3 days (September 26-28, 2018). Sanctioned amount: Rs. 1,00,000/-

Patent:
Process for isolating glycoprotein from neem leaf and its characterization to define the immunomodulatory and cancer preventive functions of this glycoprotein. Patent Number: 259434; Indian Patent Application Number: 429/KOL/2007; Publication Date: 14-Mar-2014; Grant Date: 12-Mar-2014.